CUTANEOUS B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for CUTANEOUS B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New strategy aims to tame common virus threat after stem cell transplants
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or related disorders. About 153 participants will be monitored to see if delaying or adjusting anti-CMV therapy can s…
Matched conditions: CUTANEOUS B-CELL NON-HODGKIN LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Engineered immune cells target tough lymphoma after transplant
Disease control OngoingThis early-phase study tests a new immune cell therapy for people with high-risk or returning non-Hodgkin lymphoma. After a stem cell transplant, patients receive specially engineered T-cells designed to find and attack cancer cells. The main goal is to check safety and find the …
Matched conditions: CUTANEOUS B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 16:00 UTC